483 related articles for article (PubMed ID: 20231398)
1. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Disratthakit A; Doi N
Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403
[TBL] [Abstract][Full Text] [Related]
3. New antimycobacterial S-alkylisothiosemicarbazones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
[TBL] [Abstract][Full Text] [Related]
4. New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2006; 51(1):25-6. PubMed ID: 16821707
[TBL] [Abstract][Full Text] [Related]
5. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
[TBL] [Abstract][Full Text] [Related]
7. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
Barrett MS; Jones RN; Erwin ME; Koontz FP
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
[TBL] [Abstract][Full Text] [Related]
8.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
[TBL] [Abstract][Full Text] [Related]
10. Activities of linezolid against rapidly growing mycobacteria.
Wallace RJ; Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW
Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
[TBL] [Abstract][Full Text] [Related]
11. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Udou T
J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of quinolones and macrolides against mycobacteria.
Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
15. Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST.
Lucke K; Hombach M; Friedel U; Ritter C; Böttger EC
J Antimicrob Chemother; 2012 Jan; 67(1):154-8. PubMed ID: 21965431
[TBL] [Abstract][Full Text] [Related]
16. In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.
Pucci MJ; Ackerman M; Thanassi JA; Shoen CM; Cynamon MH
Antimicrob Agents Chemother; 2010 Aug; 54(8):3478-80. PubMed ID: 20516287
[TBL] [Abstract][Full Text] [Related]
17. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
18.
Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
[TBL] [Abstract][Full Text] [Related]
19. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
20. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]